Content Navigation
( All
None )
| Protein General Information (TTD Target) |
Top |
| Full Name |
Integrin alpha-V (ITGAV)
|
Clinical trial
|
Target Info
|
| UniProt ID |
ITAV_HUMAN
|
| Gene Name |
ITGAV
|
| Gene ID |
3685
|
| Interacting TTD Target Information |
Top |
| Interacting Clinical trial Target(s) |
Integrin beta-1 (ITGB1) |
Target Info
|
PPI Info
|
[1] |
| Interacting Literature-reported Target(s) |
Integrin beta-3 (ITGB3) |
Target Info
|
PPI Info
|
[2] |
| References |
Top |
| REF 1 |
COMP-Ang1 Potentiates EPC Treatment of Ischemic Brain Injury by Enhancing Angiogenesis Through Activating AKT-mTOR Pathway and Promoting Vascular Migration Through Activating Tie2-FAK Pathway. Exp Neurobiol. 2015 Mar;24(1):55-70.
|
| REF 2 |
A Leu262Pro mutation in the integrin beta(3) subunit results in an alpha(IIb)-beta(3) complex that binds fibrin but not fibrinogen. Blood. 2000 Jul 1;96(1):161-9.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
